InterVivo Solution’s mission is to develop and provide translational animal models and transformative research services in an effort to improve the clinical success of new drugs. InterVivo provides a natural aging canine model of human diseases with a particular emphasis on AD progression, cancer, osteoarthritis, obesity and metabolic disorder. In addition to drug metabolism and pharmacokinetics screening and IND-enabling services, the company provides rodent models of cognitive function, obesity and addiction, pain and epilepsy, and Parkinson’s disease. State-of-the-art Imaging services and bioanalytical support is also provided.